BrainAurora Medical Technology Ltd
Company Profile
Business description
BrainAurora Medical Technology Ltd is a player in China's cognitive impairment digital therapeutics (the DTx) market. It has developed a medical-grade DTx product for cognitive impairment, combining brain science with artificial intelligence (the AI) technologies, Its product pipeline include range of cognitive impairments induced by vascular diseases, neurodegenerative diseases, psychiatric disorders, and child development deficiencies, among others. The company is engaged in provision of the System integral software solutions in hospitals and out of hospitals and research project. Geographically, the company generates all of its revenue from the PRC.
Contact
No. 2 Pingjiang Road
Room 1301, 13th floor, Building 3, Shaoxing
Shuimuwan District Science Park
Yuecheng District, Zhejiang Province
Shaoxing
CHNT: +86 4008053066
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
165
Stocks News & Analysis
stocks
Disney earnings: Experiences and streaming again drive excellent results
stocks
ASX utility share downgraded as electricity prices fall
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,445.10 | 33.80 | 0.36% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,668.03 | 137.75 | 0.54% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 65,606.71 | 76.55 | -0.12% |
| NZX 50 Index | 13,824.13 | 133.93 | -0.96% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,263.60 | 34.80 | 0.38% |
| SSE Composite Index | 3,940.04 | 39.68 | 1.02% |